Compare ELTX & MNTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTX | MNTS |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.6M | 41.7M |
| IPO Year | 2014 | 2019 |
| Metric | ELTX | MNTS |
|---|---|---|
| Price | $1.52 | $1.82 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 305.0K | ★ 746.7K |
| Earning Date | 11-05-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.29 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,301,000.00 | $1,110,000.00 |
| Revenue This Year | N/A | $660.36 |
| Revenue Next Year | N/A | $42.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.25 | $0.44 |
| 52 Week High | $16.00 | $22.20 |
| Indicator | ELTX | MNTS |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 30.53 |
| Support Level | $1.35 | $1.56 |
| Resistance Level | $1.98 | $2.30 |
| Average True Range (ATR) | 0.19 | 0.25 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 42.19 | 34.46 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Momentus Inc is a U.S.-based commercial space company engaged in providing satellites, satellite buses, and in-space infrastructure services. The company offers space transportation, hosted payload, and in-orbit servicing solutions, including last-mile satellite delivery, refueling, inspection, maintenance, and debris removal. It also develops satellite technologies such as solar arrays and propulsion systems, and provides production and operation of small satellites for government, defense, and commercial customers.